Jxr (01951) rose more than 5% in the afternoon, rising 4.61% to HKD 3.18 as of publication, with a turnover of HKD 29.1773 million.
According to the Wisdom Finance APP, Jxr (01951) rose more than 5% in the afternoon, rising 4.61% to HKD 3.18 as of publication, with a turnover of HKD 29.1773 million.
On the news front, Anhui is gradually including some therapeutic assisted reproductive technology projects in fund payments. In addition, the Sichuan Provincial Medical Insurance Bureau recently stated that Sichuan is pushing forward the work of "including assisted reproductive medical service projects in the scope of basic medical insurance payment" in accordance with the procedure, striving to achieve medical insurance reimbursement for related projects throughout the province by the end of 2024.
China Securities Co., Ltd. pointed out that looking forward to 2024, the policy of encouraging fertility and including assisted reproduction in medical insurance in China will continue to catalyze the industry's prosperity, and the business outlook is expected to further improve. The company will take Chengdu as a model to create integrated fertility business with assisted reproduction as the core, promote it in other hospitals in other regions, accelerate the construction of new businesses with advantages in assisted reproductive medical services market, and create new revenue growth points. In the medium and long term, the company will expand its business network through self-construction or acquisition, improve its talent recruitment and training system, and provide integrated medical services.